丧亲之痛的药物治疗：一项系统性综述。

Background: With the recent addition of prolonged grief disorder into diagnostic manuals both in the United States (i.e. DSM-5-TR) and internationally (i.e. ICD-11), interest in pharmacologic treatment for grief has increased. Objective: Here, we review how bereavement-related psychological distress, including treating depression secondary to bereavement, has been addressed pharmacologically and the efficacy of these treatments. Methods: Included studies focused on (1) patients bereaved by any cause, (2) patients suffering from bereavement-related mental health problems, and (3) pharmacotherap